Europe's pharma industry braces for tariffs as carve-out hopes fade
Hims & Hers shares rise as company adds new weight-loss medications to platform
Trump's tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
23andMe bankruptcy: With America's DNA put on sale, market panic gets a new twist
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
